Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans

被引:41
作者
Belen Florez, Ana [1 ]
Salim Ammor, Mohammed [1 ]
Alvarez-Martin, Pablo [1 ]
Margolles, Abelardo [1 ]
Mayo, Baltasar [1 ]
机构
[1] CSIC, Inst Prod Lacteos Asturias, Villaviciosa 33300, Asturias, Spain
关键词
D O I
10.1128/AEM.00486-06
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
tet(W) was found responsible for tetracycline resistance (MICs, 4 to >= 32 mu g ml(-1)) in dominant bifidobacterial species from the gastrointestinal tracts of healthy humans. The gene from Bifidobacterium longum H66 proved to be identical over a 2.6-kbp region to the recently described tet(W) determinant of Butyrivibrio fibrisolvens.
引用
收藏
页码:7377 / 7379
页数:3
相关论文
共 19 条
[1]   Evidence for recent intergeneric transfer of a new tetracycline resistance gene, tet(W), isolated from Butyrivibrio fibrisolvens, and the occurrence of tet(O) in ruminal bacteria [J].
Barbosa, TM ;
Scott, KP ;
Flint, HJ .
ENVIRONMENTAL MICROBIOLOGY, 1999, 1 (01) :53-64
[2]   Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance [J].
Chopra, I ;
Roberts, M .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2001, 65 (02) :232-+
[3]   New tetracycline resistance determinants coding for ribosomal protection in streptococci and nucleotide sequence of tet(T) isolated from Streptococcus pyogenes A498 [J].
Clermont, D ;
Chesneau, O ;
deCespedes, G ;
Horaud, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :112-116
[4]   Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract [J].
Delgado, S ;
Flórez, AB ;
Mayo, B .
CURRENT MICROBIOLOGY, 2005, 50 (04) :202-207
[5]   Antibiotic residues in poultry tissues and eggs: Human health concerns? [J].
Donoghue, DJ .
POULTRY SCIENCE, 2003, 82 (04) :618-621
[6]   Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria [J].
Klare, I ;
Konstabel, C ;
Müller-Bertling, S ;
Reissbrodtl, R ;
Huys, G ;
Vancanneyt, M ;
Swings, J ;
Goossens, H ;
Witte, W .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (12) :8982-8986
[7]   Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products [J].
Masco, L. ;
Van Hoorde, K. ;
De Brandt, E. ;
Swings, J. ;
Huys, G. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) :85-94
[8]   Genetic heterogeneity and functional properties of intestinal bifidobacteria [J].
Mättö, J ;
Malinen, E ;
Suihko, ML ;
Alander, M ;
Palva, A ;
Saarela, M .
JOURNAL OF APPLIED MICROBIOLOGY, 2004, 97 (03) :459-470
[9]  
MEIVILE CM, 2004, J BACTERIOL, V186, P3656
[10]   Antimicrobial susceptibility of bifidobacteria [J].
Moubareck, C ;
Gavini, F ;
Vaugien, L ;
Butel, MJ ;
Doucet-Populaire, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) :38-44